NOVEL SELECTIVE CYP11B1 INHIBITORS

The corticosteroid cortisol is synthesized in the adrenal cortex by a complex reaction cascade. The final step of the cortisol synthesis is catalyzed by CYP11B1. Due to the involvement of cortisol in many physiological processes a pathological overproduction might result in different diseases.

Scientist of Saarland University have now managed to develop the first CYP11B1 inhibitors showing a selective effect, i.e. they are effective on CYP11B1 nearly exclusively. Moreover the new inhibitors act with a very high degree of efficiency.

Further Information: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340

Contact
Dr. Annekathrin Seifert (Dipl.-Chem.), Dipl.-Kfm. Axel Koch (MBA), Dr. Hauke Studier (Dipl.-Phys.)

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Largest magnetic anisotropy of a molecule measured at BESSY II

At the Berlin synchrotron radiation source BESSY II, the largest magnetic anisotropy of a single molecule ever measured experimentally has been determined. The larger this anisotropy is, the better a…

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

LSU quantum researchers uncover hidden quantum behaviors within classical light, which could make quantum technologies robust. Understanding the boundary between classical and quantum physics has long been a central question…

MRI-first strategy for prostate cancer detection proves to be safe

Active monitoring is a sufficiently safe option when prostate MRI findings are negative. There are several strategies for the early detection of prostate cancer. The first step is often a…